Cargando…

Expression features of SOX9 associate with tumor progression and poor prognosis of hepatocellular carcinoma

BACKGROUND: SOX9 as a member of the SOX (SRY [sex determining region Y] box) gene superfamily has been previously demonstrated to be a proto-oncogene in a variety of malignancies. However, the clinical significance of SOX9 expression in hepatocellular carcinoma (HCC) remains unclear. The aim of this...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guo, Xiaodong, Xiong, Lu, Sun, Ting, Peng, Ruiyun, Zou, Lin, Zhu, Haiyan, Zhang, Jing, Li, Hanwei, Zhao, Jingmin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3464896/ https://www.ncbi.nlm.nih.gov/pubmed/22515642 http://dx.doi.org/10.1186/1746-1596-7-44

Ejemplares similares

L1 cell adhesion molecule overexpression in hepatocellular carcinoma associates with advanced tumor progression and poor patient survival
por: Guo, Xiaodong, et al.
Publicado: (2012)

Neutrophils: driving progression and poor prognosis in hepatocellular carcinoma?
por: Margetts, Jane, et al.
Publicado: (2018)

Over-expression of cathepsin B in hepatocellular carcinomas predicts poor prognosis of HCC patients
por: Ruan, Jian, et al.
Publicado: (2016)

Hornerin promotes tumor progression and is associated with poor prognosis in hepatocellular carcinoma
por: Fu, Shun-Jun, et al.
Publicado: (2018)

Comment on ‘Neutrophils: driving progression and poor prognosis in hepatocellular carcinoma?’
por: Liu, Yuying, et al.
Publicado: (2018)

High Expression of FLOT1 Is Associated with Progression and Poor Prognosis in Hepatocellular Carcinoma
por: Zhang, Shi-Hong, et al.
Publicado: (2013)

Increased level of nucleolin confers to aggressive tumor progression and poor prognosis in patients with hepatocellular carcinoma after hepatectomy
por: Guo, XiaoDong, et al.
Publicado: (2014)

Highly expressed RPLP2 inhibits ferroptosis to promote hepatocellular carcinoma progression and predicts poor prognosis
por: Guo, Jiaxing, et al.
Publicado: (2023)

Embryonic Morphogen Nodal Is Associated with Progression and Poor Prognosis of Hepatocellular Carcinoma
por: Chen, Jing, et al.
Publicado: (2014)

Decreased Cezanne expression is associated with the progression and poor prognosis in hepatocellular carcinoma
por: Wang, Jia-hong, et al.
Publicado: (2015)

NSUN5 promotes progression and predicts poor prognosis in hepatocellular carcinoma
por: Zhang, Xiao-Wen, et al.
Publicado: (2022)

High expression of Sox10 correlates with tumor aggressiveness and poor prognosis in human nasopharyngeal carcinoma
por: Zhao, Yu, et al.
Publicado: (2016)

Lost expression of ADAMTS5 protein associates with progression and poor prognosis of hepatocellular carcinoma
por: Li, Chongyi, et al.
Publicado: (2015)

Up-regulation of miR-9 expression predicate advanced clinicopathological features and poor prognosis in patients with hepatocellular carcinoma
por: Cai, Lizhi, et al.
Publicado: (2014)

High expression of serine and arginine-rich splicing factor 9 (SRSF9) is associated with hepatocellular carcinoma progression and a poor prognosis
por: Zhang, Guoshun, et al.
Publicado: (2022)

Prognostic and diagnostic value of SOX9 in cirrhotic and noncirrhotic hepatocellular carcinoma
por: Xu, Zhong-Ping, et al.
Publicado: (2021)

Upregulated CANT1 is correlated with poor prognosis in hepatocellular carcinoma
por: Liu, Ting, et al.
Publicado: (2023)

Upregulation of SOX9 in osteosarcoma and its association with tumor progression and patients’ prognosis
por: Zhu, Haibo, et al.
Publicado: (2013)

Serum lncRNA-ANRIL and SOX9 expression levels in glioma patients and their relationship with poor prognosis
por: Sun, Youlu, et al.
Publicado: (2021)

Ack1 overexpression promotes metastasis and indicates poor prognosis of hepatocellular carcinoma
por: Lei, Xiong, et al.
Publicado: (2015)

Serotonin and YAP/VGLL4 Balance Correlated with Progression and Poor Prognosis of Hepatocellular Carcinoma
por: Shu, Bo, et al.
Publicado: (2018)

Upregulation of cystatin SN promotes hepatocellular carcinoma progression and predicts a poor prognosis
por: Cui, Yifeng, et al.
Publicado: (2019)

Upregulation of TMCO3 Promoting Tumor Progression and Contributing to the Poor Prognosis of Hepatocellular Carcinoma
por: Dai, Tianxing, et al.
Publicado: (2022)

Overexpression of RBM34 Promotes Tumor Progression and Correlates with Poor Prognosis of Hepatocellular Carcinoma
por: Wang, Wei, et al.
Publicado: (2023)

Increased expression of G9A contributes to carcinogenesis and indicates poor prognosis in hepatocellular carcinoma
por: Qin, Jian, et al.
Publicado: (2018)

Galectin-9 expression predicts poor prognosis in hepatitis B virus-associated hepatocellular carcinoma
por: Jiao, Jianhua, et al.
Publicado: (2022)

Linc00511 Indicates A Poor Prognosis Of Liver Hepatocellular Carcinoma
por: Hu, Pingan, et al.
Publicado: (2019)

m6A-Related Genes Contribute to Poor Prognosis of Hepatocellular Carcinoma
por: Zou, Yan, et al.
Publicado: (2022)

Cytoplasmic expression of SOX9 as a poor prognostic factor for oral squamous cell carcinoma
por: Sumita, Yoshimasa, et al.
Publicado: (2018)

Increased mediator complex subunit 15 expression is associated with poor prognosis in hepatocellular carcinoma
por: Wang, Kunyuan, et al.
Publicado: (2018)

USP9X expression correlates with tumor progression and poor prognosis in esophageal squamous cell carcinoma
por: Peng, Jing, et al.
Publicado: (2013)

PRMT4 promotes hepatocellular carcinoma progression by activating AKT/mTOR signaling and indicates poor prognosis
por: Du, Peng, et al.
Publicado: (2021)

Allele Loss and Down-Regulation of Heparanase Gene Are Associated with the Progression and Poor Prognosis of Hepatocellular Carcinoma
por: Huang, Guo-Liang, et al.
Publicado: (2012)

Overexpression of microRNA let-7 correlates with disease progression and poor prognosis in hepatocellular carcinoma
por: Shi, Wenxia, et al.
Publicado: (2017)

CBX6 overexpression contributes to tumor progression and is predictive of a poor prognosis in hepatocellular carcinoma
por: Zheng, Hao, et al.
Publicado: (2017)

Low UGP2 Expression Is Associated with Tumour Progression and Predicts Poor Prognosis in Hepatocellular Carcinoma
por: Hu, Qiuyue, et al.
Publicado: (2020)

High expression of TOP2A in hepatocellular carcinoma is associated with disease progression and poor prognosis
por: Cai, Hongyu, et al.
Publicado: (2020)

Numb Promotes Cell Proliferation and Correlates with Poor Prognosis in Hepatocellular Carcinoma
por: Wu, Jian, et al.
Publicado: (2014)

CHCHD2 promotes hepatocellular carcinoma and indicates poor prognosis of hepatocellular carcinoma patients
por: Yao, Yang, et al.
Publicado: (2019)

Loss of alanine-glyoxylate and serine-pyruvate aminotransferase expression accelerated the progression of hepatocellular carcinoma and predicted poor prognosis
por: Sun, Yufeng, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_5k2gk6c5c3g2b01uq1h58u454j